Skip to main content

Table 4 Results of cost-effectiveness analysis when only direct health care costs were considered in the analysis

From: Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece

Direct comparison Total cost Incremental cost ICER
   Agomelatine vs. comparator  
Agomelatine €1,970 - -
Venlafaxine €1,620 €350 €13,682/QALY
Sertraline €1,701 €269 €7,959/QALY
Escitalopram €1,816 €154 €10,591/QALY
Fluoxetine €1,697 €273 €9,183/QALY
Generic Venlafaxine €1,597 €373 €14,581/QALY
Generic Sertraline €1,651 €319 €9,434/QALY
Generic Escitalopram €1,740 €230 €15,799/QALY
Generic Fluoxetine €1,642 €328 €11,027/QALY
  1. QALY: Quality Adjusted Life Year.
  2. ICER: Incremental cost effectiveness ratio.